Company: Eli Lilly and CompanyTitle: Executive Vice President & Chief Financial OfficerIndustry: PharmaceuticalsHometown: Tel Aviv, IsraelNotable in 2023: Helped to manage a big revenue boost, investment in new manufacturing, jobs, and plan to lower insulin prices.
Anat Ashkenazi was key to helping Eli Lilly and Company reach new heights in 2023.
As the company’s CFO, she managed the windfall of revenue from its weight loss and diabetes drugs. The treatments exploded in popularity over the last year for their ability to help patients shed significant pounds over time. Sales from the diabetes drug Mounjaro, which exceeded $5 billion in its first full year on the market, and the fast launch of the newly approved weight loss injection Zepbound, helped catapult Eli Lilly’s revenue to more than $34 billion in 2023, up 20% from the previous year.
That success, along with the potential of highly-anticipated drugs such as the Alzheimer’s treatment donanemab…